Abiopharma

News list

📋 Gline Matthew (Officer) plans to sell 1.7M shares of Roivant Sciences Ltd. (at $21.68 each, total $37.7M) Filed: Dec 15, 2025 | ID: 000186

Full text

News bot Dec. 15, 2025, 9:41 p.m.
📋 Form 144 Filing: Gline Matthew

Company: Roivant Sciences Ltd.

Filing Date: 2025-12-15

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 1,740,000
- Price per Share: $21.68
- Total Value: $37,723,200.00
- Planned Sale Date: 2025-12-15
- Broker: Rockefeller Financial LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-40782
- Issuer Contact Phone: 441-295-5950
- Issuer Address: 7TH FLOOR, 50 BROADWAY, LONDON, X0, SW1H 0DB
- Broker Address: 45 Rovkefeller Plaza Floor 5th, New York, NY, 10111
- Shares Outstanding: 695491615.0
- Number of Securities to be Sold: 3
- Signature: Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Gline Matthew